Can iron deficiency cause reactive thrombocytosis with elevated platelet counts?

An analysis of the medical evidence regarding the relationship between iron deficiency and elevated platelet counts yields the following findings:

Clinical evidence and therapeutic reversibility

• Causal relationship: Ample clinical and experimental evidence demonstrates that iron deficiency directly drives reactive thrombocytosis. Observational data reveal a strong inverse correlation between platelet counts and key iron markers (including serum ferritin, transferrin saturation, and serum iron), along with a positive correlation with total iron-binding capacity (TIBC).
• Response to therapy: The reactive nature of this condition is confirmed by its rapid response to iron replacement therapy. Restoring iron stores typically leads to a steady decline and normalization of platelet counts within weeks to months. For example, pediatric studies demonstrate that up to 92% of patients achieve normal platelet counts within one month of initiating iron supplementation.

Mechanistic explanations

• Progenitor lineage biasing: Animal models show that iron restriction directly biases hematopoietic stem and progenitor cells toward the megakaryocytic lineage. It actively stimulates megakaryocyte differentiation, increases ploidy, and accelerates proplatelet formation.
• TPO-independent pathway: Interestingly, this thrombocytotic response occurs largely independently of thrombopoietin (TPO), the primary hormone regulating platelet production.
• EPO-driven amplification: Instead, the mechanism is heavily mediated by elevated erythropoietin (EPO) levels, which rise in response to anemia or tissue hypoxia. Because erythropoiesis is restricted at iron-dependent stages, this heightened EPO signal is redirected to stimulate shared erythroid-megakaryocytic progenitors, thereby amplifying reactive thrombocytosis.

Bottom line

Iron deficiency is a clinically established, reversible cause of reactive thrombocytosis. The condition is driven by a combination of TPO-independent megakaryocytic lineage biasing and EPO-mediated progenitor stimulation, both of which reliably normalize following adequate iron repletion.